Understanding the Potential Drug Targets and Biomarkers of Neuregulin-3 (NRG3)

Target Name: NRG3

NCBI ID: G10718

NRG3

Understanding the Potential Drug Targets and Biomarkers of Neuregulin-3 (NRG3)

Neuregulin-3 (NRG3) is a protein that is expressed in various tissues throughout the body, including the nervous system, endothelial cells, and epithelial cells. It is a potent signaling molecule that plays a role in cell proliferation, differentiation, and survival. In recent years, researchers have become increasingly interested in investigating the potential drug targets and biomarkers for NRG3.

NRG3 has been shown to be involved in a wide range of physiological processes, including cell signaling, angiogenesis, and cancer progression. Its functions have been attributed to its role in several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.

One of the most significant functions of NRG3 is its role in cell signaling. NRG3 has been shown to play a negative role in cell proliferation, by inhibiting the activity of the oncogene transforming growth factor-尾 (TGF-β). This means that when TGF-β is activated, NRG3 helps to prevent cell proliferation. This function makes NRG3 an attractive drug target, as it has the potential to be used for the treatment of various types of cancer.

Another function of NRG3 is its role in angiogenesis. NRG3 has been shown to promote the formation of new blood vessels in response to the presence of a specific signaling molecule, called SDF-1. This means that when SDF-1 is administered to cancer cells, NRG3 helps to stimulate the formation of new blood vessels, which can lead to the development of new tumors. This function makes NRG3 a potential biomarker for cancer diagnosis and treatment.

In addition to its functions in cell signaling and angiogenesis, NRG3 has also been shown to play a role in cancer progression. Studies have shown that NRG3 is often overexpressed in various types of cancer, and that its overexpression can contribute to the development and progression of these diseases. This makes NRG3 an attractive drug target, as it has the potential to be used for the treatment of various types of cancer.

Overall, NRG3 is a protein that has a wide range of functions in various tissues throughout the body. Its functions have been attributed to its role in several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. As a result, NRG3 has become an increasingly popular drug target, with potential applications in the treatment of various types of cancer.

Protein Name: Neuregulin 3

Functions: Direct ligand for the ERBB4 tyrosine kinase receptor. Binding results in ligand-stimulated tyrosine phosphorylation and activation of the receptor. Does not bind to the EGF receptor, ERBB2 or ERBB3 receptors. May be a survival factor for oligodendrocytes

The "NRG3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NRG3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets